Skip to main content
. Author manuscript; available in PMC: 2015 Jun 2.
Published in final edited form as: Lung Cancer. 2014 Jun 16;85(2):282–292. doi: 10.1016/j.lungcan.2014.05.025

Fig. 4.

Fig. 4

Modulation of Ras expression by LATS2. (A) Cells were transfected with siRNA for LATS2 (siLATS2), Negative Control siRNA (siCont) or none (Mock Control) for 48 h. Cellular lysates were analyzed by Western blotting with the indicated antibodies. Number below each blot indicates fold change to mock control (n = 3).